What is the controversy around hormone therapy for menopause? Elizabeth Tracey reports

from Johns Hopkins Medicine · host Johns Hopkins Medicine

The FDA has recently removed black box warnings, indicating a medication is potentially risky, from hormone therapy for menopause. The warning was originally put on in 2003 after a study seemed to show increased risks for cardiovascular disease, breast cancer … What is the controversy around hormone therapy for menopause? Elizabeth Tracey reports Read More »

Episode metadata supplied by the publisher feed · Published Jan 26, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

What is the controversy around hormone therapy for menopause? Elizabeth Tracey reports

0:00 1:02

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Johns Hopkins Medicine?

This episode is 1 minute long.

When was this Johns Hopkins Medicine episode published?

This episode was published on January 26, 2026.

Can I download this Johns Hopkins Medicine episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!